CD4 and cancer: To summarize, we assume that the observed reduction in the number of IFN-gamma-producing CD4+ T cells might be simultaneously associated with an increased release of IFN-gamma into the cancer cell micro-environment in triple-negative MDA-MB-231 cancer cells.